[Thiopurine treatment. Significance of pharmacogenetic polymorphism].
Schmiegelow
K
K
H:S Rigshospitalet, Juliane Marie Centret, paediatrisk klinik. rh02133@rh.dk
Hertz
H
H
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001379:Azathioprine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011110:Polymorphism, Genetic
D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine; D001379:Azathioprine
Thiopurinbehandling. Betydning af farmakogenetisk polymorfi.